Exclusive

Publication

Byline

Location

Clinical Trial: Evaluation of an Interprofessional Education Class Based on a Communication Education Program Connecting Healthcare Professionals and Deaf People: A Quantitative Study Using the Japanese Version of the Readiness for Interprofessional Learning Scale (Japan)

Tokyo, May 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061674) titled 'Evaluation of a Class for Healthcare Students on Medical Communication with ... Read More


Clinical Trial: ENtire ABLation rEgistry of Osaka CardioVascular Conference: ENABLE-OCVC (Japan)

Tokyo, May 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061664) titled 'ENtire ABLation rEgistry of Osaka CardioVascular Conference: ENABLE-OCVC' on... Read More


Clinical Trial: Construction of a case database for lung cancer surgery cases (Japan)

Tokyo, May 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061663) titled 'Construction of a case database for lung cancer surgery cases' on May 25. S... Read More


Clinical Trial: Molecular, Cellular, and Spatial Analysis of Granulomas in Crohn's Disease (Japan)

Tokyo, May 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061595) titled 'Molecular, Cellular, and Spatial Analysis of Granulomas in Crohn's Disease' ... Read More


Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, May 24 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension (PALM-PAH)

Singapore, May 24 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evalu... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Efficacy of Efimosfermin Alfa in Participants With Biopsy-Confirmed F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-1)

Singapore, May 24 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, May 24 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY4302814 in Healthy Participants

Singapore, May 24 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY4302814 in Healthy Participants

Singapore, May 24 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More